1/10
01:07 am
iobt
High
Report
1/8
07:09 am
iobt
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "underweight" rating.
Medium
Report
IO Biotech (NASDAQ:IOBT) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "underweight" rating.
12/29
01:08 am
iobt
12/21
01:08 am
iobt
Medium
Report
12/16
04:38 pm
iobt
IO Biotech (NASDAQ:IOBT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
IO Biotech (NASDAQ:IOBT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
12/15
04:21 pm
iobt
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications [Yahoo! Finance]
Medium
Report
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications [Yahoo! Finance]
12/15
04:05 pm
iobt
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
Low
Report
IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications
12/13
01:10 am
iobt
11/26
11:45 am
iobt
IO Biotech Announces Participation in Upcoming December Investor Conferences [Yahoo! Finance]
Low
Report
IO Biotech Announces Participation in Upcoming December Investor Conferences [Yahoo! Finance]
11/26
10:46 am
iobt
IO Biotech Announces Participation in Upcoming December Investor Conferences
Low
Report
IO Biotech Announces Participation in Upcoming December Investor Conferences
11/23
02:11 am
iobt
Low
Report
11/19
01:13 pm
iobt
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why [Yahoo! Finance]
Low
Report
IO Biotech, Inc. (IOBT) Upgraded to Buy: Here's Why [Yahoo! Finance]
11/14
08:36 am
iobt
IO Biotech GAAP EPS of -$0.13 beats by $0.25 [Seeking Alpha]
Medium
Report
IO Biotech GAAP EPS of -$0.13 beats by $0.25 [Seeking Alpha]
11/14
08:11 am
iobt
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
Medium
Report
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
11/14
08:05 am
iobt
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
Low
Report
IO Biotech Reports Third Quarter 2025 Financial Results and Provides Business Highlights
11/12
01:26 pm
iobt
IO Biotech (NASDAQ:IOBT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
IO Biotech (NASDAQ:IOBT) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
08:30 am
iobt
IO Biotech Announces Participation in Upcoming Investor Conferences
Medium
Report
IO Biotech Announces Participation in Upcoming Investor Conferences
11/7
09:00 am
iobt
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
Medium
Report
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
10/22
10:01 am
iobt
IO Biotech (NASDAQ:IOBT) was given a new $3.00 price target on by analysts at Piper Sandler.
High
Report
IO Biotech (NASDAQ:IOBT) was given a new $3.00 price target on by analysts at Piper Sandler.